Bipolar Depression vs. Unipolar Depression: Why the Difference Matters for Treatment

By Kyle Roth, FNP-BC, APRN, MSN, MHA | Roth Family Medicine and Mental Health | Pocatello, Idaho

One of the most consequential — and most commonly missed — distinctions in mental health care is the difference between bipolar depression and unipolar depression. Both conditions involve profound sadness, low energy, and loss of interest in life. Both can be debilitating. But they are fundamentally different illnesses that require fundamentally different treatments.

Getting this distinction wrong doesn't just mean slow progress. It can mean years of worsening symptoms, medication-induced mood cycling, and a growing sense that nothing will ever work.

Unipolar depression — formally called Major Depressive Disorder (MDD) — is characterized by depressive episodes without any history of mania or hypomania. The "unipolar" label refers to the fact that mood only swings in one direction: down.

Symptoms of a major depressive episode include:

• Persistent sadness or emptiness lasting two weeks or more
• Loss of interest or pleasure in activities once enjoyed (anhedonia)
• Fatigue and loss of energy
• Changes in sleep (insomnia or hypersomnia)
• Changes in appetite or weight
• Difficulty concentrating or making decisions
• Feelings of worthlessness or excessive guilt
• Thoughts of death or suicide

MDD affects approximately 21 million American adults — about 8.3% of the population — making it one of the most prevalent mental health conditions in the country.

Bipolar disorder is a mood disorder characterized by episodes of both depression and mania (or hypomania). The depressive phase of bipolar disorder can look virtually identical to MDD — the same low mood, fatigue, and hopelessness. But the presence of manic or hypomanic episodes changes everything about how the condition should be treated.

There are three main types of bipolar disorder:

Bipolar I involves full manic episodes lasting at least seven days (or requiring hospitalization), often alternating with major depressive episodes. Mania at this level typically involves dramatically decreased need for sleep, grandiosity, racing thoughts, impulsive behavior, and sometimes psychosis.

Bipolar II involves hypomanic episodes — a milder form of mania that doesn't cause severe impairment — alternating with major depressive episodes. Many people with Bipolar II spend far more time depressed than hypomanic, which is why it's so frequently misdiagnosed as MDD.

Cyclothymia involves chronic mood instability with hypomanic and depressive symptoms that don't fully meet criteria for either Bipolar I or II.

Studies suggest that up to 40% of people with bipolar disorder are initially misdiagnosed — most commonly with MDD. There are several reasons for this:

Patients present during depression. Most people seek help when they're depressed, not when they're feeling elevated or energized. If a provider only sees the depressive phase, bipolar disorder may not be on the radar.

Hypomania often doesn't feel like a problem. In Bipolar II, hypomanic episodes can feel like periods of high productivity, creativity, and confidence. Patients may not report them as symptoms — or may not even recognize them as abnormal.

The diagnostic criteria overlap significantly. The depressive symptoms of bipolar disorder are nearly identical to those of MDD. Without a thorough history that specifically probes for past manic or hypomanic episodes, the distinction is easy to miss.

Stigma around bipolar disorder. Some patients resist the bipolar diagnosis, which can lead to incomplete disclosure of symptoms.

This is where the stakes become very high. The standard first-line treatment for MDD is antidepressant medication — SSRIs, SNRIs, or other agents. But in bipolar disorder, antidepressants used without a mood stabilizer can trigger serious problems:

• Mood switching: Antidepressants can precipitate a manic or hypomanic episode in people with bipolar disorder
• Rapid cycling: Some patients develop rapid cycling (four or more mood episodes per year) when treated with antidepressants alone
• Mixed states: Antidepressants can induce mixed episodes — a dangerous combination of depressive and manic symptoms simultaneously
• Treatment resistance: Patients with unrecognized bipolar disorder who are treated with antidepressants often appear "treatment-resistant" — not because their depression can't be treated, but because they're being treated for the wrong condition

This is one reason why a thorough evaluation of treatment history and mood patterns is essential before labeling someone as having treatment-resistant depression.

While only a qualified clinician can make a definitive diagnosis, there are several features that raise suspicion for bipolar disorder rather than MDD:

When bipolar depression is correctly identified, treatment looks very different from MDD:

Mood stabilizers are the cornerstone of bipolar treatment. Lithium, valproate, and lamotrigine all have evidence for bipolar depression. Lithium in particular has the strongest evidence base and is the only medication shown to reduce suicide risk in bipolar disorder.

Atypical antipsychotics such as quetiapine, lurasidone, and cariprazine have FDA approval for bipolar depression and are commonly used as first-line agents.

Antidepressants are used cautiously if at all — typically only in combination with a mood stabilizer, and only when other options have been exhausted.

Ketamine therapy has emerging evidence in bipolar depression, particularly for acute suicidality and treatment-resistant bipolar depression. Its rapid onset of action makes it valuable in crisis situations.

TMS (Transcranial Magnetic Stimulation) has been studied in bipolar depression with promising results, though it requires careful monitoring for mood switching.

Psychotherapy — particularly Cognitive Behavioral Therapy (CBT) adapted for bipolar disorder and Interpersonal and Social Rhythm Therapy (IPSRT) — plays an important role in long-term management.

For true unipolar MDD, the treatment landscape is broader:

• SSRIs and SNRIs remain first-line pharmacological options
• Augmentation strategies (adding lithium, atypical antipsychotics, or thyroid hormone to antidepressants) for partial responders
• Ketamine therapy for treatment-resistant MDD — one of the most effective interventions available for patients who haven't responded to multiple antidepressants
• TMS therapy for treatment-resistant MDD — FDA-cleared and highly effective for many patients
• Psychotherapy — CBT, behavioral activation, and other evidence-based approaches

At Roth Family Medicine and Mental Health, we take a thorough, integrative approach to mood disorder evaluation. Before recommending any treatment, we conduct a comprehensive assessment that includes:

• Detailed personal and family psychiatric history
• Screening for past hypomanic or manic episodes using validated tools
• Review of prior medication responses and side effects
• Assessment of medical contributors (thyroid, hormones, inflammation)
• Evaluation of sleep patterns, substance use, and life stressors

If you've been treated for depression without adequate response, or if you've had unusual reactions to antidepressants, it's worth exploring whether bipolar disorder might be part of the picture.

The right diagnosis is the foundation of effective treatment. We're here to help you find it.

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner at Roth Family Medicine and Mental Health in Pocatello, Idaho, specializing in treatment-resistant depression, ketamine therapy, TMS, hormone optimization, and integrative mental health care. To schedule a consultation, visit ZocDoc or call (208) 904-4705.